Publication

Duan S, Zinkeng A, Sawyer T, Merchant J, Twer A, Naciri I, Moore J, Gentry R, Sontz R, Ayabe R, et al. 2026 Feb. 21. Hedgehog signaling drives glial cell plasticity and oncogenic reprogramming in gastroenteropancreatic neuroendocrine neoplasms. Molecular Cancer. doi:10.1186/s12943-026-02611-y.

Liu T, Roorkeewal J, Furlong MA, Beitel SC, Burgess JL, Lee BR, Chipollini J, Snider JM, Batai K. 2025. Evaluating Differential Metabolic Profiles by Prostate Cancer Risk Among Prostate Cancer Patients. Metabolites. 15(12):757. doi:10.3390/metabo15120757.

Larkey LK, James DL, Han S, Weihs K, Jahnke R, Oh B, Kim SW, Huberty J, Petrov ME, Martin D, et al. 2025. Randomized controlled trial testing Tai Chi Easy/Qigong and Sham Qigong on breast cancer survivors’ fatigue and associated symptoms. Complementary Therapies in Clinical Practice. 61:102014. doi:10.1016/j.ctcp.2025.102014.

Adams AC, Macy AM, Borden ES, Herrmann LM, Brambley CA, Sonar SA, Ma T, Li X, Hughes A, Roe DJ, et al. 2025. Structural changes from wild-type define tumor-rejecting neoantigens. Journal for ImmunoTherapy of Cancer. 13(10):e013148. doi:10.1136/jitc-2025-013148.

Borden ES, Hastings CT, Prakash N, Kuo T, Tapia E, Yozwiak M, Sagerman P, Vargas de Stefano D, Buetow KH, Wilson MA, et al. 2025. Towards a transcriptomic biomarker for the classification of melanocytic neoplasms. Sun S, editor. PLOS Genetics. 21(10):e1011869. doi:10.1371/journal.pgen.1011869.

Wang Z, Li W, Jiang Y, Ma T, Li M, Wu S, Tran TB, Cordova LE, Lin E, Scott AJ, et al. 2025 Aug. A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancer. Nature Cancer. doi:10.1038/s43018-025-01029-7.

Brown HE, Pauli L, Dholakia R, Gunderson J, Jernberg J, Sanderson PR, Harris RB, Monroy FP. 2025. Helicobacter pylori Diagnostic Testing Accuracy in a High-Prevalence Native American Population of Northern Arizona. Microorganisms. 13(8):1920. doi:10.3390/microorganisms13081920.

Chen X, Shen Y, Choi S, Abdel-Hafiz HA, Basu M, Hoelzen L, Tufano M, Kailasam Mani SK, Ranjpour M, Zhu J, et al. 2025. Concurrent loss of the Y chromosome in cancer and T cells impacts outcome. Nature. 642(8069):1041–1050. doi:10.1038/s41586-025-09071-2.

Magnus JH, Nguyen LT, Alevy EG, Sawyer TW, Crossley SD, Kieu K. 2025. Fifth-harmonic and five-photon excitation fluorescence multiphoton microscopy. Optics Letters. 50(12):3931. doi:10.1364/ol.566910.

Chauhan SS, Vizzerra AD, Liou H, Flores CE, Snider AJ, Snider JM, Warfel NA. 2025. Hypoxia induced lipid droplet accumulation promotes resistance to ferroptosis in prostate cancer. Oncotarget. 16(1):532–544. doi:10.18632/oncotarget.28750.

Sonar SA, Bhat R, Thompson HL, Coplen CP, Uhrlaub JL, Jergović M, Nikolich J Ž.. 2025 May. Age‐Related Oxidative Stress and Mitochondrial Dysfunction in Lymph Node Stromal Cells Limit the Peripheral T Cell Homeostatic Maintenance and Function. Aging Cell. doi:10.1111/acel.70100.

Bonaventura J, Lima N, Routh J, Alameri A, Bomman S, Banerjee B, Gavini H, Sawyer T. 2025. Multimodal esophageal cancer imaging: establishing data processing techniques and assessing diagnostic sensitivity. Biophotonics Discovery. 2(02). doi:10.1117/1.bios.2.2.022704.

Abdelrahim M, Esmail A, Kim RD, Arora SP, Arshad J, Kournoutas IA, O’Donnell CD, Totev TI, Tan A, Mu F, et al. 2025. Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study. Cancers. 17(11):1814. doi:10.3390/cancers17111814.

Marcarian HQ, Sivakoses A, Arias AM, Ihedioha OC, Lee BR, Bishop MC, Bothwell ALM. 2025. Renal cancer cells acquire immune surface protein through trogocytosis and horizontal gene transfer. Fujiwara K, editor. PLOS One. 20(5):e0325043. doi:10.1371/journal.pone.0325043.

Wallace R, Smith I, Day D, Alexander M, Weihs KL, Wiley JF. 2025 Apr. A randomized controlled trial: Evaluating whether a cognitive behavioral internet-delivered intervention targeting emotion regulation improves health-related quality of life in cancer survivors. Health Psychology. doi:10.1037/hea0001497.

Lang SM, Truong DT, Powell AJ, Kazlova V, Newburger JW, Awerbach JD, Binka E, Bradford TT, Cartoski M, Cheng A, et al. 2025 Apr. CMR Findings in the Long-Term Outcomes After Multisystem Inflammatory Syndrome in Children (MUSIC) Study. Circulation: Cardiovascular Imaging. doi:10.1161/circimaging.124.017420.

Baker FL, Stokes J, Cracchiolo MJ, Davini D, Simpson RJ, Katsanis E. 2025. Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial. Frontiers in Immunology. 16. doi:10.3389/fimmu.2025.1568862.

Pontifex T, Yang X, Tracy A, Craig Z, Zhou C. 2025. Prenatal exposure to environmentally relevant low-dosage dibutyl phthalate reduces placental efficiency in CD-1 mice. Toxicological Sciences. 206(1):86–95. doi:10.1093/toxsci/kfaf050.

Burgess JL, Beitel SC, Calkins MM, Furlong MA, Louzado Feliciano P, Kolar Gabriel J, Grant C, Goodrich JM, Graber JM, Healy O, et al. 2025. The Fire Fighter Cancer Cohort Study: Protocol for a Longitudinal Occupational Cohort Study. JMIR Research Protocols. 14:e70522. doi:10.2196/70522.

Farrera DO, Alaaldin MM, Lindberg P, Sample PA, Lenzen-Hammerel P, LaMadrid CS, Haymore R, Wright SH, Cherrington NJ. 2025. Alterations of valsartan pharmacokinetics in a rodent model of metabolic dysfunction–associated steatohepatitis. Drug Metabolism and Disposition. 53(3):100043. doi:10.1016/j.dmd.2025.100043.

Martinez-Guerrero L, Vignaux PA, Harris JS, Lane TR, Urbina F, Wright SH, Ekins S, Cherrington NJ. 2025. Computational Approaches for Predicting Drug Interactions with Human Organic Anion Transporter 4 (OAT4). Molecular Pharmaceutics. 22(4):1847–1858. doi:10.1021/acs.molpharmaceut.4c00984.

Tandon V, Fistrovich A, Nogales J, Ferro F, Rokey SN, Cabel C, Miller AD, Yagel M, Duncan C, Atmasidha A, et al. 2025 Mar. Dyr726, a brain-penetrant inhibitor of PI3Kα, Type III receptor tyrosine kinases, and WNT signaling. doi:10.1101/2025.03.26.645490.

Sarami I, Hekman KE, Gupta AK, Snider JM, Ivancic D, Zec M, Kandpal M, Ben-Sahra I, Menon R, Otto EA, et al. 2025 Mar. Parallel multiOMIC analysis reveals glutamine deprivation enhances directed differentiation of renal organoids. doi:10.1101/2025.02.27.640060.

Carew JS, Espitia CM, Sureshkumar S, Carrera Espinoza MJ, Gamble ME, Wang W, Lee BR, Nawrocki ST. 2025. REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activity. Cancer Letters. 613:217496. doi:10.1016/j.canlet.2025.217496.

Deressa BT, Pierz A, Jyung H, Rosario B, Andoh-B-Baidoo N, Tibebu B, Seife E, Bekele E, Hussein R, Gedif T, et al. 2025 Feb. A qualitative study on the psycho-oncological experiences of women navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia. Journal of Cancer Survivorship. doi:10.1007/s11764-024-01742-9.